Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| IL31R | Q8NI17 | Interleukin-31 receptor subunit alpha (IL-31 receptor subunit alpha) (IL-31R subunit alpha) (IL-31R-alpha) (IL-31RA) (Cytokine receptor-like 3) (GLM-R) (hGLM-R) (Gp130-like monocyte receptor) (Gp130-like receptor) (ZcytoR17) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| IL6RB | P40189 | Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ILDR2 | Q71H61 | Immunoglobulin-like domain-containing receptor 2 (Angulin-3) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| INGR1 | P15260 | Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119) | CD markersDisease related genesFDA approved drug targets | 1 | Clinical-translation mediationImmune mediation | 1 | 0.50 | |||
| IRAG2 | Q12912 | Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2] | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ITA3 | P26006 | Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain] | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ITA4 | P13612 | Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d) | 1 | AsthmaCerebral ischaemic strokeCrohn disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| ITA7 | Q13683 | Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form] | Disease related genesHuman disease related genesPotential drug targets | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ITB2 | P05107 | Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18) | CD markersDisease related genesHuman disease related genes | 1 | Cerebral ischaemiaInnate/adaptive immunodeficiencyIschaemic/haemorrhagic stroke | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| ITB5 | P18084 | Integrin beta-5 | Cancer-related genesPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| ITB7 | P26010 | Integrin beta-7 (Gut homing receptor beta subunit) | 1 | Crohn diseaseUlcerative colitis | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 1 | 0.50 | |||
| ITB8 | P26012 | Integrin beta-8 | Cancer-related genesPredicted membrane proteins | 1 | Chronic kidney disease | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 1 | 0.50 | ||
| IYD1 | Q6PHW0 | Iodotyrosine deiodinase 1 (IYD-1) (EC 1.21.1.1) (Iodotyrosine dehalogenase 1) | Disease related genesEnzymesHuman disease related genes | 1 | Metabolism mediation | 1 | 0.50 | |||
| JAG1 | P78504 | Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339) | CD markersDisease related genesHuman disease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| JAML | Q86YT9 | Junctional adhesion molecule-like (Adhesion molecule interacting with CXADR antigen 1) (Dendritic cell-specific protein CREA7-1) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| KCNA6 | P17658 | Potassium voltage-gated channel subfamily A member 6 (Voltage-gated potassium channel HBK2) (Voltage-gated potassium channel subunit Kv1.6) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNA7 | Q96RP8 | Potassium voltage-gated channel subfamily A member 7 (Voltage-gated potassium channel subunit Kv1.7) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNB2 | Q92953 | Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNE3 | Q9Y6H6 | Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (MiRP2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2) | Disease related genesHuman disease related genesPotential drug targets | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| KCNG4 | Q8TDN1 | Voltage-gated potassium channel regulatory subunit KCNG4 (Potassium voltage-gated channel subfamily G member 4) (Voltage-gated potassium channel subunit Kv6.3) (Voltage-gated potassium channel subunit Kv6.4) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNK6 | Q9Y257 | Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence) | Predicted membrane proteinsTransportersVoltage-gated ion channels | 4 | Fusion and delivery mediation | 1 | 0.50 | |||
| KCNK9 | Q9NPC2 | Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2) (Two pore K(+) channel KT3.2) | 4 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNS1 | Q96KK3 | Delayed-rectifier potassium channel regulatory subunit KCNS1 (Delayed-rectifier K(+) channel alpha subunit 1) (Delayed-rectifier potassium channel subunit Kv9.1) (hKv9.1) (Potassium voltage-gated channel modifier subfamily S member 1) | 6 | Fusion and delivery mediation | 1 | 0.50 | ||||
| KCNT1 | Q5JUK3 | Potassium channel subfamily T member 1 (KCa4.1) (KNa1.1) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.2) | Disease related genesHuman disease related genesPotential drug targets | 6 | Acute myeloid leukaemiaHodgkin lymphoma | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| KIT | P10721 | Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117) | Cancer-related genesCD markersDisease related genes | 1 | Acute myeloid leukaemiaAlzheimer diseaseBone/articular cartilage neoplasm | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.50 |